Carbohydrate antigen 19-9 elevation without evidence ... | 合法醫療器材資訊網

Elevated serum CA 19-9 · a CA 19-9 of >100 U/mL may have a sensitivity of 50% in diagnosing cholangiocarcinoma · when it is elevated with proven malignancy,​ ... Read More

由 S Kim 著作 · 2020 · 被引用 7 次 — CA 19-9 is often elevated in benign pancreatobiliary diseases such as cholangitis, obstructive jaundice and pancreatitis. Additionally, it has been ... Read More

由 S Pavai 著作 · 2003 · 被引用 97 次 — CA 19-9 was found to be elevated in malignancies of pancreas, colorectum, lung, liver and ovary. Benign conditions associated with elevation of CA 19-9 included​ ... Read More

由 H Cho 著作 · 2013 · 被引用 48 次 — Tumor markers in MCT were compared to those in OC. Results: MCTs with CA19-​9 elevation were correlated with a larger diameter (8.53±3.84 ... Read More

由 Z Wen 著作 · 2017 · 被引用 29 次 — Elevation of CA19-9 and CEA is associated with a poor prognosis in patients with resectable gallbladder carcinoma · Authors · Affiliations. Read More

CA19-9 can be elevated in many types of gastrointestinal cancer, such as colorectal cancer, esophageal cancer and hepatocellular carcinoma. ... Apart from cancer, ... Read More

由 M Howaizi 著作 · 2003 · 被引用 29 次 — CA 19.9 (sialyl lewis-a) is a monosialoganglioside with small increases in a number of benign diseases, with highest levels in pancreatic adenocarcinoma, ... Read More

由 S Kim 著作 · 2020 · 被引用 7 次 — CA 19-9 is often elevated in benign pancreatobiliary diseases such as cholangitis, obstructive jaundice and pancreatitis. Additionally, it has been ... Read More

由 M Howaizi 著作 · 2003 · 被引用 29 次 — Serum carbohydrate associated antigen (CA19.9) is a reliable tumour marker of biliopancreatic malignancies. A number of benign diseases are also known to be​ ... Read More